CCR2 and lung cancer: IHC with antibody against F4/80 was performed to confirm the induction of macrophage infiltration, which can be promoted by up‐regulation of ERα expression in lung cancer cells, and can partly be blocked by treatment with CCR2 antagonist or fulvestrant.